Moog Inc. Cl A (MOG.A) Drops 17.5% on January 29

Equities Staff |

Moog Inc. Cl A (MOG.A) was one of the Russell 2000's biggest losers for Friday January 29 as the stock slid 17.5% to $45.50, a loss of $-9.65 per share. Starting at an opening price of $50.00 a share, the stock traded between $44.82 and $50.64 over the course of the trading day. Volume was 293,466 shares over 2,801 trades, against an average daily volume of 143,484 shares and a total float of 33.9 million.

The losses send Moog Inc. Cl A down to a market cap of $1.54 billion. In the last year, Moog Inc. Cl A has traded between $77.28 and $50.78, and its 50-day SMA is currently $60.92 and 200-day SMA is $64.35.

The stock has a P/E Ratio of 16.6.

Moog Inc is a designer, manufacturer and integrator of precision motion and fluid controls and systems for applications in aerospace and defense, and industrial markets.

Moog Inc. Cl A is based out of New York, NY and has some 10,691 employees. Its CEO is John R. Scannell.

For a complete fundamental analysis analysis of Moog Inc. Cl A, check out’s Stock Valuation Analysis report for MOG.A. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…